CV admissions on the rise in Americans with cancerAugust 9, 2022Patient & Survivor CareLung CancerPreventive Care
FDA approves trastuzumab-deruxtecan for HER2-low breast cancerAugust 5, 2022Metastatic Breast CancerBreast Cancer
New blood test could reshape early CRC screeningAugust 5, 2022GastroenterologyGastrointestinal Cancer
‘Misleading’ focus on urinary symptoms preventing early prostate cancer diagnosesAugust 5, 2022Preventive CareGenitourinary Cancer
Patient CRC screening preferences don’t match what they’re being offeredAugust 4, 2022GastroenterologyGastrointestinal Cancer
Should patients undergoing surgical treatment for cervical lesions also receive an HPV vaccination?August 4, 2022Gynecologic CancerPreventive Care
One in four NSCLC patients respond poorly to COVID-19 vaccineAugust 3, 2022Lung CancerCOVID-19 Updates
Taste dysfunction in head and neck cancer due to radiation doseAugust 3, 2022Head & Neck/Thyroid Cancers
Devices to detect skin cancer: FDA advisers offer mixed viewsAugust 2, 2022Nonmelanoma Skin CancerMelanoma
Node-negative triple-negative breast cancer prognosis lies within stromal lymphocytesAugust 2, 2022Metastatic Breast CancerBreast Cancer
Higher ADR continues to show ‘strong, consistent’ link with lower interval CRCAugust 1, 2022GastroenterologyGastrointestinal Cancer
